Nothing Special   »   [go: up one dir, main page]

IT8123546A0 - Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative - Google Patents

Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative

Info

Publication number
IT8123546A0
IT8123546A0 IT8123546A IT2354681A IT8123546A0 IT 8123546 A0 IT8123546 A0 IT 8123546A0 IT 8123546 A IT8123546 A IT 8123546A IT 2354681 A IT2354681 A IT 2354681A IT 8123546 A0 IT8123546 A0 IT 8123546A0
Authority
IT
Italy
Prior art keywords
antiulcera
activity
procedure
compound
preparation
Prior art date
Application number
IT8123546A
Other languages
English (en)
Other versions
IT1168163B (it
Inventor
Leonardo De Vincentiis
Original Assignee
Ausonia Farma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11208027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT8123546(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of IT8123546A0 publication Critical patent/IT8123546A0/it
Priority to IT23546/81A priority Critical patent/IT1168163B/it
Application filed by Ausonia Farma Srl filed Critical Ausonia Farma Srl
Priority to CH4612/82A priority patent/CH650259A5/it
Priority to AU86731/82A priority patent/AU533719B2/en
Priority to US06/405,332 priority patent/US4431664A/en
Priority to ZA825718A priority patent/ZA825718B/xx
Priority to DK357182A priority patent/DK156067C/da
Priority to NLAANVRAGE8203160,A priority patent/NL186447C/xx
Priority to SE8204670A priority patent/SE448456B/sv
Priority to BE2/59796A priority patent/BE894093A/nl
Priority to CA000409313A priority patent/CA1182121A/en
Priority to FR8214079A priority patent/FR2511675A1/fr
Priority to GR69044A priority patent/GR76260B/el
Priority to JP57141602A priority patent/JPS5859982A/ja
Priority to GB08223316A priority patent/GB2104071B/en
Priority to PH27729A priority patent/PH19228A/en
Priority to DE3230265A priority patent/DE3230265C2/de
Priority to AT0312282A priority patent/AT383597B/de
Priority to KR8203689A priority patent/KR860000851B1/ko
Priority to NO822801A priority patent/NO159448C/no
Priority to MX603682A priority patent/MX154876A/es
Priority to ES515068A priority patent/ES8306372A1/es
Priority to LU84340A priority patent/LU84340A1/fr
Priority to PT75440A priority patent/PT75440B/pt
Priority to AR290336A priority patent/AR230444A1/es
Publication of IT1168163B publication Critical patent/IT1168163B/it
Application granted granted Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IT23546/81A 1981-08-18 1981-08-18 Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative IT1168163B (it)

Priority Applications (24)

Application Number Priority Date Filing Date Title
IT23546/81A IT1168163B (it) 1981-08-18 1981-08-18 Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative
CH4612/82A CH650259A5 (it) 1981-08-18 1982-07-30 Composto ad attivita antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative.
AU86731/82A AU533719B2 (en) 1981-08-18 1982-08-04 Furanyl methylenedioxybenzyl derivatives
US06/405,332 US4431664A (en) 1981-08-18 1982-08-05 Compound with antiulcerogenic activity, process for the preparation thereof and pharmaceutical composition therefrom
ZA825718A ZA825718B (en) 1981-08-18 1982-08-06 Compound with antiulcerogenic activity, process for the preparation thereof and pharmaceutical compositions therefrom
DK357182A DK156067C (da) 1981-08-18 1982-08-09 Analogifremgangsmaade til fremstilling af n-(2-((5-(dimethylamino-methyl)-2-furanyl)-methylthio)-ethyl)-n'-(3,4-methylendioxybenzyl)-2-nitro-1,1-ethendiamin
NLAANVRAGE8203160,A NL186447C (nl) 1981-08-18 1982-08-11 Verbinding met anti-ulcerogene activiteit, werkwijze voor het bereiden daarvan en farmaceutische preparaten die deze stof bevatten.
SE8204670A SE448456B (sv) 1981-08-18 1982-08-12 N-(2-(((5-(dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioxibensyl)-2-nitro-1,1-etendiamin, forfarande for dess framstellning samt farmaceutisk beredning innehallande densamma
BE2/59796A BE894093A (nl) 1981-08-18 1982-08-12 Nieuwe verbinding met anti-ulcerogene activiteit, werkwijze voor het bereiden daarvan en farmaceutische preparaten die deze stof bevatten
CA000409313A CA1182121A (en) 1981-08-18 1982-08-12 Compound with antiulcerogenic activity, process for the preparation thereof and pharmaceutical composition therefrom
PH27729A PH19228A (en) 1981-08-18 1982-08-13 N-(2-(((5-dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'(3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine,process for the preparation thereof and pharmaceutical composition thereof
GR69044A GR76260B (it) 1981-08-18 1982-08-13
FR8214079A FR2511675A1 (fr) 1981-08-18 1982-08-13 N-(2- (((5- dimetnylamino)-methyl-2-furanyl)-methyl)thio)-ethyl)-n'- (3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine, son procede de preparation et son application en therapeutique
JP57141602A JPS5859982A (ja) 1981-08-18 1982-08-13 Ｎ−（２−（（５−ジメチルアミノメチル）−２−フラニル−メチルチオ）−エチル）−ｎ′−（３，４−メチレンジオキシベンジル）−２−ニトロ−１，１−エテンジアミン、その製造法およびそれを有効成分とする抗潰瘍剤
GB08223316A GB2104071B (en) 1981-08-18 1982-08-13 Furan derivatives
DE3230265A DE3230265C2 (de) 1981-08-18 1982-08-14 N-[2-(((5-Dimethylamino)-methyl-2-furanyl)-methyl)-thioethyl]-N'-(3,4-methylendioxybenzyl)-2-nitro-1,1-ethendiamin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittelzubereitungen
ES515068A ES8306372A1 (es) 1981-08-18 1982-08-17 "procedimiento para la preparacion de n-(2-(((5-dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-(3,4-metilendioxibencil)-2-nitro-1,1-etendiamina".
KR8203689A KR860000851B1 (ko) 1981-08-18 1982-08-17 N-(2-(((5-(디메틸아미노)-메틸-2-푸라닐)-메틸)-티오)-에틸)-n'-(3,4-메틸렌-디옥시벤질)-2-니트로-1,1-에텐디아민의 제조방법
AT0312282A AT383597B (de) 1981-08-18 1982-08-17 Verfahren zur herstellung des neuen n-(2-(((5it81081823546/8
NO822801A NO159448C (no) 1981-08-18 1982-08-17 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin.
MX603682A MX154876A (es) 1981-08-18 1982-08-17 Procedimiento para la preparacion de n-(2-(((5-(dimetilamino)-metil-2-furanil)-metil)-tio)etil)-(n'-(3,4-metilendioxibencil)-2-nitro-1-1-etendiamina
LU84340A LU84340A1 (fr) 1981-08-18 1982-08-18 N-(2-(((5-(dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'-(3,4-methylenedioxy-benzyl)-2-nitro-1,1-ethenediamine,son procede de preparation et son application en therapeutique
PT75440A PT75440B (en) 1981-08-18 1982-08-18 Preparation process of n-<2-<<<<5-(dimethylamino)-methyl-2-furanyl>-methyl>>-thio-ethyl>-n'-(3,4-methylenedioxidebenzyl)-2-n itro-1,1-ethenediamine with anti-ulcerous activity and pharm aceutic compositions therewith
AR290336A AR230444A1 (es) 1981-08-18 1982-08-18 Procedimiento para la preparacion de n-(2-(((5-dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-(3,4-metilendioxibenol)-2-nitro 1,1-etendiamina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23546/81A IT1168163B (it) 1981-08-18 1981-08-18 Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative

Publications (2)

Publication Number Publication Date
IT8123546A0 true IT8123546A0 (it) 1981-08-18
IT1168163B IT1168163B (it) 1987-05-20

Family

ID=11208027

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23546/81A IT1168163B (it) 1981-08-18 1981-08-18 Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative

Country Status (23)

Country Link
US (1) US4431664A (it)
JP (1) JPS5859982A (it)
KR (1) KR860000851B1 (it)
AR (1) AR230444A1 (it)
AT (1) AT383597B (it)
AU (1) AU533719B2 (it)
BE (1) BE894093A (it)
CA (1) CA1182121A (it)
CH (1) CH650259A5 (it)
DE (1) DE3230265C2 (it)
DK (1) DK156067C (it)
ES (1) ES8306372A1 (it)
FR (1) FR2511675A1 (it)
GB (1) GB2104071B (it)
GR (1) GR76260B (it)
IT (1) IT1168163B (it)
LU (1) LU84340A1 (it)
NL (1) NL186447C (it)
NO (1) NO159448C (it)
PH (1) PH19228A (it)
PT (1) PT75440B (it)
SE (1) SE448456B (it)
ZA (1) ZA825718B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1175808B (it) * 1984-03-07 1987-07-15 Ausonia Farma Srl Procedimento per la preparazione di composto con attivita' antiulcera
IT1196133B (it) * 1984-06-06 1988-11-10 Ausonia Farma Srl Derivati furanici con attivita' antiulcera
KR950009825B1 (ko) * 1986-03-28 1995-08-29 자누스 화마스티씨 에스.알.엘. 치료학적 항궤양 활성이 있는 니페로티딘의 합성방법
HU9203905D0 (en) * 1989-04-05 1993-04-28 Glaxo Group Ltd Method for producing ranitidine
JPH0416036U (it) * 1990-05-31 1992-02-10

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140681A (en) * 1974-11-08 1979-02-20 Mitsubishi Chemical Industries, Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PT75440A (en) 1982-09-01
BE894093A (nl) 1982-12-01
NO159448C (no) 1988-12-28
AT383597B (de) 1987-07-27
NO159448B (no) 1988-09-19
NL186447B (nl) 1990-07-02
JPS5859982A (ja) 1983-04-09
GB2104071A (en) 1983-03-02
CA1182121A (en) 1985-02-05
NO822801L (no) 1983-02-21
ES515068A0 (es) 1983-06-01
FR2511675A1 (fr) 1983-02-25
DK156067B (da) 1989-06-19
DE3230265A1 (de) 1983-03-03
AU533719B2 (en) 1983-12-08
DK357182A (da) 1983-02-19
GB2104071B (en) 1985-03-27
KR860000851B1 (ko) 1986-07-09
SE448456B (sv) 1987-02-23
SE8204670L (sv) 1983-02-19
SE8204670D0 (sv) 1982-08-12
DK156067C (da) 1989-12-04
LU84340A1 (fr) 1983-02-28
CH650259A5 (it) 1985-07-15
US4431664A (en) 1984-02-14
NL186447C (nl) 1990-12-03
ATA312282A (de) 1986-12-15
NL8203160A (nl) 1983-03-16
AU8673182A (en) 1983-02-24
JPS6335631B2 (it) 1988-07-15
FR2511675B1 (it) 1984-02-10
ES8306372A1 (es) 1983-06-01
PH19228A (en) 1986-02-12
ZA825718B (en) 1983-06-29
KR840001162A (ko) 1984-03-28
GR76260B (it) 1984-08-04
PT75440B (en) 1986-02-04
AR230444A1 (es) 1984-04-30
DE3230265C2 (de) 1984-09-20
IT1168163B (it) 1987-05-20

Similar Documents

Publication Publication Date Title
IT1190727B (it) Composto ad attivita&#39; analgesica,antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche
IT8324035A0 (it) Cefem composti ad attivita&#39;farmaceutica e procedimenti per laloro preparazione.
IT8421241A0 (it) Composti ad attivita&#39;antibatterica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT8123546A0 (it) Composto ad attivita&#39; antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative
IT8223770A0 (it) Composto ad attivita&#39;vasodilatatrice, antiaggregante e ipocolesterolemizzante, procedimento per la sua preparazione e composizione farmaceutiche relative.
IT1167746B (it) Nitroimidazoli ad attivita&#39; tricomonacida, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8121960A0 (it) Composti ad attivita&#39; gaba simile, procedimento per prepararli e composizioni farmaceutiche cheli comprendono.
IT1168068B (it) Composto ad attvita&#39; antiinfiammatoria, disinfettante e antibatterica, procedimento per la sua preparazione e relative composizioni farmaceutiche
IT1137375B (it) Composto ad attivita&#39; vasodilatatrice periferica utile come rubefacente, procedimento per la sua preparazione e composizioni farmaceutiche a base di detto composto
IT1168067B (it) Composto ad attivita&#39; antibatterica, procedimento per la sua preparazione e composizioni farmaceutiche relative
IT1147325B (it) Composto ad attivita&#39; psicostimolante e antidepressiva,processo per la sua preparazione e composizioni farmaceutiche relative
IT8219214A0 (it) Composto ad attivita&#39; mucoregolatri ce e fluidificante,procedimento per la sua preparazione e relative composizioni farmaceutiche
IT8219901A0 (it) Composto ad attivita&#39; antivirale, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8219455A0 (it) Composto ad attivita&#39;analgesica, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8521925A0 (it) Composto ad attivita&#39;lassativa, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8423852A0 (it) Composto ad attivita&#39;analettica respiratoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8121620A0 (it) Broncosecretolitica e composto ad attivita&#39;antitussigena, procedimenti per lasua preparazione e relative composizioni farmaceutiche.
IT8220037A0 (it) Composto ad attivita&#39; antiarteriosclerotica,antitrombotica e antiaggrecante piastrinica,procedimento per la sua prerapazione e relative composizioni farmaceutiche
IT8721158A0 (it) Composto ad attivita&#39;antiinfiammatoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT1190728B (it) Composto ad attivita&#39; analgesica,antiinfiammatoria e antipiretica,procedimento per la sua preparazione e relative composizioni farmaceutiche
IT8222339A0 (it) Composti ad attivita&#39;calcio-antagonista, metodo per laloro preparazione e composizioni farmaceutiche.
IT8219215A0 (it) Composto ad attivita&#39; analgesica, antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche
IT8521504A0 (it) Composto ad attivita&#39;antiinfiammatoria e antibatterica, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8820927A0 (it) Composto ad attivita&#39;antiinfiammatoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8419115A0 (it) Composto ad attivita&#39;antitrombotica e antiaterosclerotica, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono.